Cigna’s new chief medical officer begins as different execs depart the corporate

Editorial Team
3 Min Read


This audio is auto-generated. Please tell us you probably have suggestions.

Identify: Dr. Amy Flaster

Earlier title: Chief medical officer, Cigna Healthcare

New title: Chief medical officer, Cigna

Flaster joined Cigna late final yr because the CMO of the Connecticut-based firm’s medical health insurance arm. However now, she’s getting into an expanded position as CMO of all the enterprise, encompassing each Cigna Healthcare and well being providers division Evernorth.

Beginning Nov. 1, Flaster is main Cigna’s efforts to enhance medical efficiency, together with testing and introducing new care fashions, overseeing suppliers and figuring out the place expertise might be an asset.

Flaster, a training main care doctor, began her profession at Brigham and Ladies’s Hospital in Boston earlier than founding a well being IT platform for advance directive documentation, in line with her LinkedIn. She then pivoted to hospital management, becoming a member of Companions HealthCare — now referred to as Mass Common Brigham — as affiliate medical director in 2016.

Flaster additionally led inhabitants well being technique for knowledge and analytics firm Well being Catalyst earlier than transitioning to ConcertoCare, a value-based residence care supplier for seniors, as chief medical officer in 2021.

At Cigna, Flaster will report back to COO Brian Evanko.

Her appointment coincides with the departure of Dr. David Brailer, a longtime healthcare govt who served as Cigna’s chief well being officer since 2022.

Cigna didn’t reply to questions on Brailer’s departure and whether or not the CHO position would proceed previous his exit. Brailer was the primary to carry the put up.

Equally, Cigna’s head of enterprise enchancment and innovation Chris DeRosa can also be departing to retire after greater than twenty years on the firm.

Cigna additionally introduced that Katya Andresen, Cigna’s chief digital and analytics officer, will oversee the corporate’s “excellence and transformation” efforts, which shapes buyer engagement.

Like different insurers, Cigna has been attempting to extend client belief at a troublesome time for the trade. Healthcare prices have been rising, significantly in authorities applications, slicing into payer income. In the meantime, shoppers, regulators and lawmakers are up-in-arms about improper delays and denials of medical care.

Cigna pledged to make healthcare extra reasonably priced and simpler to entry in January, one month after the killing of the highest govt of rival insurer UnitedHealthcare kickstarted trade soul-searching about worsening public sentiment.

Since then, the corporate has moved to tie govt compensation to buyer satisfaction, reshuffled its C-suite, pledged to reform controversial utilization administration methods and shared plans to maneuver away from much-maligned rebates in its pharmacy advantages supervisor.

Share This Article